Literature DB >> 30805918

[Fragile X associated tremor/ataxia syndrome: its clinical presentation, pathology, and treatment].

M J Salcedo-Arellano1, R J Hagerman1, V Martinez-Cerdeno1,2.   

Abstract

The fragile X associated tremor/ataxia syndrome (FXTAS) is a neurodegenerative disease associated with the repetition of CGG triplets (55-200 CGG repetitions) in the FMR1 gene. The premutation of the FMR1 gene, contrasting with the full mutation (more than 200 CGG repetitions), presents an increased production of messenger and a similar or slightly decreased production of FMRP protein. FXTAS affects 40% of men and 16% of women carriers of the premutation. It presents with a wide constellation of neurological signs such as intention tremor, cerebellar ataxia, parkinsonism, executive function deficits, peripheral neuropathy and cognitive decline leading to dementia among others. In this review, we present what is currently known about the molecular mechanism, the radiological findings and the pathology, as well as the complexity of the diagnosis and management of FXTAS.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30805918      PMCID: PMC7001878          DOI: 10.33588/rn.6805.2018457

Source DB:  PubMed          Journal:  Rev Neurol        ISSN: 0210-0010            Impact factor:   0.870


  78 in total

1.  Fragile X-associated tremor ataxia syndrome in FMR1 gray zone allele carriers.

Authors:  Deborah Hall; Flora Tassone; Olga Klepitskaya; Maureen Leehey
Journal:  Mov Disord       Date:  2011-12-11       Impact factor: 10.338

2.  Elevated levels of FMR1 mRNA in carrier males: a new mechanism of involvement in the fragile-X syndrome.

Authors:  F Tassone; R J Hagerman; A K Taylor; L W Gane; T E Godfrey; P J Hagerman
Journal:  Am J Hum Genet       Date:  2000-01       Impact factor: 11.025

3.  Broad autism spectrum and obsessive-compulsive symptoms in adults with the fragile X premutation.

Authors:  A Schneider; C Johnston; F Tassone; S Sansone; R J Hagerman; E Ferrer; S M Rivera; D Hessl
Journal:  Clin Neuropsychol       Date:  2016-06-29       Impact factor: 3.535

4.  Parkinsonism in fragile X-associated tremor/ataxia syndrome (FXTAS): revisited.

Authors:  Yu-Qiong Niu; Jin-Chen Yang; Deborah A Hall; Maureen A Leehey; Flora Tassone; John M Olichney; Randi J Hagerman; Lin Zhang
Journal:  Parkinsonism Relat Disord       Date:  2014-01-18       Impact factor: 4.891

5.  Lifetime prevalence of mood and anxiety disorders in fragile X premutation carriers.

Authors:  James A Bourgeois; Andreea L Seritan; E Melina Casillas; David Hessl; Andrea Schneider; Ying Yang; Inderjeet Kaur; Jennifer B Cogswell; Danh V Nguyen; Randi J Hagerman
Journal:  J Clin Psychiatry       Date:  2010-08-24       Impact factor: 4.384

Review 6.  RAN translation-What makes it run?

Authors:  Katelyn M Green; Alexander E Linsalata; Peter K Todd
Journal:  Brain Res       Date:  2016-04-06       Impact factor: 3.252

Review 7.  Gamma knife radiosurgery in movement disorders: Indications and limitations.

Authors:  Yoshinori Higuchi; Shinji Matsuda; Toru Serizawa
Journal:  Mov Disord       Date:  2016-03-31       Impact factor: 10.338

8.  CGG repeat length correlates with age of onset of motor signs of the fragile X-associated tremor/ataxia syndrome (FXTAS).

Authors:  Flora Tassone; John Adams; Elizabeth M Berry-Kravis; Susannah S Cohen; Alfredo Brusco; Maureen A Leehey; Lexin Li; Randi J Hagerman; Paul J Hagerman
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2007-06-05       Impact factor: 3.568

9.  Expansion of the fragile X CGG repeat in females with premutation or intermediate alleles.

Authors:  Sarah L Nolin; W Ted Brown; Anne Glicksman; George E Houck; Alice D Gargano; Amy Sullivan; Valérie Biancalana; Karen Bröndum-Nielsen; Helle Hjalgrim; Elke Holinski-Feder; Frank Kooy; John Longshore; James Macpherson; Jean-Louis Mandel; Gert Matthijs; Francois Rousseau; Peter Steinbach; Marja-Leena Väisänen; Harriet von Koskull; Stephanie L Sherman
Journal:  Am J Hum Genet       Date:  2003-01-14       Impact factor: 11.025

10.  Making a Difference-Positive Effect of Unilateral VIM Gamma Knife Thalamotomy in the Therapy of Tremor in Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS).

Authors:  Piotr Alster; Dariusz M Koziorowski; Mirosław Za Bek; Sebastian Dzierzȩcki; Jacek Ma Dry; Karolina Duszyńska-Wa S; Hanna Grygarowicz; Justyna Zielonko; Leszek Królicki; Andrzej Friedman
Journal:  Front Neurol       Date:  2018-06-27       Impact factor: 4.003

View more
  2 in total

Review 1.  Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS): Pathophysiology and Clinical Implications.

Authors:  Ana Maria Cabal-Herrera; Nattaporn Tassanakijpanich; Maria Jimena Salcedo-Arellano; Randi J Hagerman
Journal:  Int J Mol Sci       Date:  2020-06-20       Impact factor: 5.923

Review 2.  Fragile X Premutation: Medications, Therapy and Lifestyle Advice.

Authors:  Deepika Kour Sodhi; Randi Hagerman
Journal:  Pharmgenomics Pers Med       Date:  2021-12-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.